Surgical Instruments Catalog German Engineering
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Mediastinoscopic Esophagectomy with Lymph Node Dissection Using a Bilateral Transcervical and Transhiatal Pneumomediastinal Approach
Tokairin et al. Mini-invasive Surg 2020;4:32 Mini-invasive Surgery DOI: 10.20517/2574-1225.2020.23 Technical Note Open Access Mediastinoscopic esophagectomy with lymph node dissection using a bilateral transcervical and transhiatal pneumomediastinal approach Yutaka Tokairin1,2, Yasuaki Nakajima2, Kenro Kawad2, Akihiro Hoshin2, Takuya Okada2, Toshihiro Matsui2, Kazuya Yamaguchi2, Kagami Nagai2, Yusuke Kinugasa2 1Department of Surgery, Toshima Hospital Tokyo Metropolitan Health and Hospitals Corporation, Tokyo 173-0015, Japan. 2Department of Gastrointestinal Surgery, Tokyo Medical and Dental University, Tokyo 113-8510, Japan. Correspondence to: Dr. Yutaka Tokairin, Department of Surgery, Toshima Hospital Tokyo Metropolitan Health and Hospitals Corporation, 33-1 Sakaecho, Itabashi-ku, Tokyo 173-0015, Japan. E-mail: [email protected] How to cite this article: Tokairin Y, Nakajima Y, Kawad K, Hoshin A, Okada T, Matsui T, Yamaguchi K, Nagai K, Kinugasa Y. Mediastinoscopic esophagectomy with lymph node dissection using a bilateral transcervical and transhiatal pneumomediastinal approach. Mini-invasive Surg 2020;4:32. http://dx.doi.org/10.20517/2574-1225.2020.23 Received: 17 Feb 2020 First Decision: 17 Mar 2020 Revised: 24 Mar 2020 Accepted: 1 Apr 2020 Published: 16 May 2020 Science Editor: Itasu Ninomiya Copy Editor: Jing-Wen Zhang Production Editor: Tian Zhang Abstract We developed a method for mediastinoscopic esophagectomy via a bilateral transcervical and transhiatal approach under pneumomediastinum as a less-invasive radical operation. The right recurrent nerve is first identified using an open approach, and the right cervical paraesophageal lymph nodes and part of the right recurrent nerve lymph nodes are dissected, after which pneumomediastinum is initiated. -
Surgical Instrument Catalogue
Company Profile Dixons Surgical Instruments Ltd is a leading UK manufacturer of Surgical and Orthopaedic Instruments. We specialise in the manufacture of Precision Medical Devices and can offer a full service from Design, through Prototyping and on to Full Production Runs. The company was founded in November 1948 by Frank Dixon in Caledonian Road, London before moving to Leigh-On-Sea, Essex in 1956. Frank's son, John Dixon, joined the company in 1960 and trained in all aspects of the business. On the death of his Father in 1979, John took over as Managing Director. He was joined shortly after by his wife, Joan Dixon, who became the Financial Director. The company steadily expanded over the years and in 1989 it moved from the site in Leigh-On-Sea to a purpose built factory in Wickford, Essex, approximately 30 miles (50 Km) east of London. John and Joan's son, Jay Dixon, joined the company in 1990 and carried out a 5 year apprenticeship as a Surgical Instrument Maker. He then followed in his Father’s footsteps by training in all other aspects of the business, becoming Technical Director in 2004. In 2010 Jay Dixon was appointed Managing Director, while John Dixon moved into the role of Chairman. Joan Dixon continues to be the Financial Director. Today our Surgical and Orthopaedic Instruments are manufactured at our Wickford factory using a combination of the latest CNC controlled machines, along with the manual skills of our experienced craftsmen. This approach enables us to make Surgical and Orthopaedic Instruments in the most accurate and efficient way possible whilst still retaining that finishing touch required for truly excellent instruments. -
Hybrid Video-Assisted Thoracoscopic Surgery Sleeve Lobectomy for Non-Small Cell Lung Cancer: a Case Report
6846 iMDT Corner Hybrid video-assisted thoracoscopic surgery sleeve lobectomy for non-small cell lung cancer: a case report Chenlei Zhang1, Zhanwu Yu1, Jijia Li1, Peng Zu1, Pingwen Yu1, Gebang Wang1, Takuro Miyazaki2, Ryuichi Waseda3, Raul Caso4, Giulio Maurizi5, Hongxu Liu1 1Department of Thoracic Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China; 2Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; 3Department of General Thoracic, Breast, and Pediatric Surgery, Fukuoka University, Fukuoka, Japan; 4Department of Surgery, MedStar Georgetown University Hospital, Washington, DC, USA; 5Department of Thoracic Surgery, Sant’Andrea Hospital, Sapienza University of Rome, Rome, Italy Correspondence to: Hongxu Liu. Department of Thoracic Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, No.44 Xiaoheyan Road, Dadong District, Shenyang 110042, China. Email: [email protected]. Submitted Feb 04, 2020. Accepted for publication Oct 24, 2020. doi: 10.21037/jtd-20-2679 View this article at: http://dx.doi.org/10.21037/jtd-20-2679 Introduction procedure. Also, hybrid VATS SL is a safer approach, especially in patients with infiltration of the pulmonary Lung cancer continues to be the leading cause of cancer- artery (PA), as it makes the surgeon more comfortable related death in China and worldwide (1,2). Sleeve during the bronchial and arterial anastomoses. Literatures lobectomy (SL) and pneumonectomy are surgical options for have shown that hybrid VATS approach has advantages for the treatment of locally advanced non-small cell lung cancer select T3 chest wall lung cancers (13) and superior sulcus (NSCLC). SL was initially intended as a parenchyma- tumors (14) over conventional open surgery. -
NCCN Guidelines for Patients: Non-Small Cell Lung Cancer
NCCN.org/patients/surveyPlease complete our online survey at NCCN Guidelines for Patients® Version 1.2016 Lung Cancer NON–SMALL CELL LUNG CANCER Presented with support from: Available online at NCCN.org/patients Ü NCCN Guidelines for Patients® Version 1.2016 Lung Cancer NON-SMALL CELL LUNG CANCER Learning that you have cancer can be overwhelming. The goal of this book is to help you get the best cancer treatment. It explains which cancer tests and treatments are recommended by experts of non-small cell lung cancer. The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of 27 of the world’s leading cancer centers. Experts from NCCN have written treatment guidelines for doctors who treat lung cancer. These treatment guidelines suggest what the best practice is for cancer care. The information in this patient book is based on the guidelines written for doctors. This book focuses on the treatment of non-small cell lung cancer. Key points of the book are summarized in the related NCCN Quick Guide™. NCCN also offers patient resources on lung cancer screening as well as other cancer types. Visit NCCN.org/patients for the full library of patient books, summaries, and other patient and caregiver resources. ® NCCN Guidelines for Patients i Lung Cancer – Non-Small Cell, Version 1.2016 Endorsers and sponsors Endorsed and sponsored in part by LUNG CANCER ALLIANCE LUNG CANCER RESEARCH COUNCIL Lung Cancer Alliance is proud to collaborate with National Comprehensive As an organization that seeks to increase public awareness and Cancer Network to sponsor and endorse these NCCN Guidelines for understanding about lung cancer and support programs for screening and Patients®: Non–Small Cell Lung Cancer. -
22Nd European Conference on General Thoracic Surgery ABSTRACTS
22ND EUROPEAO N C NFERENCE ON GENERAL THORACIC SURGERY COPENHAGEN – DENMARK 2014 22 nd European Conference European onGeneral ABSTRACTS 15 –18June2014 Copenhagen www.ests.org of Thoracic of Thoracic Surgeons SocietyEuropean – Thoracic SurgeryThoracic Denmark 22nd European Conference on General Thoracic Surgery 15 – 18 June 2014 Bella Center, Copenhagen, Denmark 01 ests2014_toc.indd 1 14.05.2014 14:05:18 22nd European Conference on General Thoracic Surgery 2 01 ests2014_toc.indd 2 14.05.2014 14:05:18 Copenhagen – Denmark – 2014 TABLE OF CONTENTS TABLE OF CONTENTS Monday, 16 June 2014 Session I/ Brompton 5 Session II/ Videos 17 Session III/ Pulmonary Non Neoplastic 23 Session IV/ Young Investigators Award 32 Session V/ Pulmonary Neoplastic I 51 Session VI/ Innovative/Experimental 63 Oscar Night Videos 78 Tuesday, 17 June 2014 Session VIII/ Mixed Thoracic I 85 Session IX/ Mixed Thoracic II 97 Session X/ Pulmonary Neoplastic II 109 Session XI/ Videos II 123 Session XII/ Interesting Cases 129 Session XIII/ Oesophagus/Mediastinum 134 Session XIV/ Airway/Transplantation 146 Session XV/ Chest Wall/Diaphragm/Pleura 155 Session XVI/ MITIG – VATS RESECTIONS 166 Posters 178 Nurse Symposium-Oral 332 Nurse Symposium-Posters 342 List of Authors 361 3 01 ests2014_toc.indd 3 14.05.2014 14:05:18 22nd European Conference on General Thoracic Surgery ABSTRACTS 4 02_ests2014.indd 4 14.05.2014 14:07:30 Abstracts 001 - 006 Copenhagen – Denmark – 2014 ABSTRACTS Monday A.M. MONDAY, 16 JUNE 2014 08:30 - 10:30 SESSION I: BROMPTON B-001 ERGON – TRIAL: ERGONOMIC EVALUATION OF SINGLE-PORT ACCESS VERSUS THREE-PORT ACCESS VIDEO-ASSISTED THORACIC SURGERY Luca Bertolaccini1, A. -
Medicure Instruments
MEDICURE edicure Instruments MED CURE MedicurM e Instruments MI-503 MI-502 MI-501 KOCHER’S MOSQUITO FORCEPS FORCEPS SPENCER WELLS ARTERY FORCEPS STAINLESS STEEL STRAIGHT ARTERY MI-504 MI-505 MI-506 MI-507 MI-508 KOCHER’S DISSECTING FORCEPS DISSECTING FORCEPS RUSSIAN DISSECTING FINE DISSECTING FORCEPS STAINLESS STEEL - PLAIN STAINLESS STEEL - TOOTH FORCEPS FORCEPS - PLAIN CURVED ARTERY MI-509 MI-510 MI-511 TOWEL CLIP FINE DISSECTING DENNIS BROWNE TOWEL FORCEPS CROSS-ACTION FORCEPS - TOOTH DISSECTING FORCEPS BACKHAUS GENERAL SURGERY INSTRUMENTS MEDICURE edicure Instruments MED CURE MedicurM e Instruments MI-512 MI-513 MI-513 MI-514 LISTER SINUS B.P. HANDLE NO. 3 B.P. HANDLE NO. 4 B.P. HANDLE NO. 7 MALLEBLE PROBE DRESSING FORCEPS WITH EYE MI-515 MI-5164 MI-514 BOZEMANN KILNER MI-517 MAYO HEGARS NEEDLE HOLDERS NEEDLE HOLDERS FINE DRESSING SCISSORS NEEDLE HOLDERS STRAIGHT STRAIGHT STRAIGHT (SHARP x BLUNT) STRAIGHT STAINLESS STEEL STAINLESS STEEL STAINLESS STEEL STAINLESS STEEL MI-521 MI-518 MI-519 MI-520 STITCH RIBBON SCISSORS DRESSING SCISSORS IRIS SCISSORS KNAPP SCISSORS STRAIGHT STRAIGHT (SHARP x SHARP) STRAIGHT STRAIGHT STAINLESS STEEL STAINLESS STEEL STAINLESS STEEL STAINLESS STEEL GENERAL SURGERY INSTRUMENTS MEDICURE edicure Instruments MED CURE MedicurM e Instruments MI-523 MI-524 MI-525 STEVENS SCISSORS MAYO SCISSORS GREEN BERG SCISSORS MI-522 STRAIGHT STRAIGHT (KILNER) METZENBAUM SCISSORS STAINLESS STEEL STRAIGHT STAINLESS STEEL STRAIGHT STAINLESS STEEL STAINLESS STEEL MI-528 MI-529 ALLIS TISSUE POTT’S ANGLED GRASPING FORCEPS MI-526 -
Alternative – Universal Extended Video Mediastinoscopy with Distending, Narrow Blades Extended Video Mediastinoscopy with Distending, Tapered Blade System
THOR 19 2.0 11/2020-E Alternative – Universal Extended video mediastinoscopy with distending, narrow blades Extended video mediastinoscopy with distending, tapered blade system By creating visibility and space, video mediastinoscopy allows the precise display and dissection of mediastinal structures and is therefore valuable for lymph node staging. Mediastinal staging as well as extended or complex endoscopic interventions, including video-assisted mediastinoscopic lymphadenectomy (VAMLA), can be performed with the aid of a distending video mediastinoscope system. KARL STORZ offers an atraumatic, easy-to-use, compact blade system with a holding arm device and an integrated irrigation and suction channel for this purpose. Two adjustment wheels in the handle allow distal distension of the blades and height adjustment in parallel. Combined with a matching HOPKINS® wide angle telescope, this autoclavable blade system provides the operating surgeon with an optimal overview of the working area. In conjunction with a holding arm with KSLOCK, bimanual work is also possible. The corresponding DCI® camera head IMAGE1 S™ D1 is operated via the modular KARL STORZ IMAGE1 S™ camera platform. Consequently, the system is likely to experience a renaissance in the coming years. We also offer instruments and other accessories that are compatible with the system. © KARL STORZ 96082019 THOR 19 2.0 11/2020 EW-E 2 Components of the KARL STORZ video mediastinoscopy system for extended mediastinoscopy Monitor 27" FULL HD Monitor TM220 Camera System IMAGE1 S CONNECT® -
STILLE Surgical Instruments Kirurgisk Perfektion I Närmare 180 År Surgical Perfection for Almost 180 Years
STILLE Surgical Instruments Kirurgisk perfektion i närmare 180 år Surgical Perfection for almost 180 years I närmare 180 år har vi utvecklat och tillverkat de bästa kirurgiska For almost 180 years, we have developed and manufactured the best instrumenten till världens mest krävande kirurger. Vi vill rikta ett stort surgical instruments for the world’s most demanding surgeons. tack till alla våra trogna kunder och samtidigt välkomna våra nya kunder. We would like to extend a heartfelt thank you to all our loyal I den här katalogen presenterar vi vårt kompletta sortiment av customers and a warm welcome to our new customers. In this catalog STILLEs original instrument. we present our complete range of STILLE original surgical instruments. Precision, hållbarhet och känsla är typiska egenskaper för alla Precision, durability and feel are characteristic qualities of all STILLE STILLE-instrument. Den stora majoriteten är handgjorda av våra instruments. The vast majority are handcrafted by our highly skilled skickliga instrumentmakare Eskilstuna. Instrumentets resa från rundstål instrument makers in Eskilstuna, west of Stockholm, Sweden. The instru- till ett färdigt instrument är lång, och består av många tillverkningssteg. ments’ journey from a rod of stainless steel to a finished instrument is a STILLEs unika tillverkningsmetod och användning av enbart det bästa long one, involving multiple stages. STILLE’s unique method of crafting its materialet ger våra instrument deras unika känsla och hållbarhet. instrument materials, and its usage of only the very highest-grade steels, give our instruments their unique feel and durability. I det första kapitlet hittar du våra saxar, allt från vanliga operationssaxar till våra unika SuperCut och Diamond SuperCut-saxar. -
Mediastinoscopy: a Clinical Evaluation of 400 Consecutive Cases
Thorax: first published as 10.1136/thx.24.5.585 on 1 September 1969. Downloaded from Thorax (1969), 24, 585. Mediastinoscopy: A clinical evaluation of 400 consecutive cases C. L. SARIN1 AND H. C. NOHL-OSER From the Thoracic Surgical Unit, Harefield Hospital, Harefield, Middlesex Mediastinoscopy was carried out in 400 cases, including 296 of bronchogenic carcinoma. At the time of presentation the new growth had already spread to involve the mediastinal lymph nodes in slightly more than 50% of these. The incidence of involvement was 76% in oat-cell and 35% in squamous-cell carcinoma. Non-resectability at thoracotomy was encountered in seven out of 120 patients. We advocate this procedure in every case of bronchogenic carcinoma which is considered operable on other counts. In patients in whom the mediastinal lymph nodes are invaded by growth we prefer radical radiotherapy to surgery, as the long-term survival of the two methods is comparable. This procedure may be the only source of positive histological proof of diagnosis, not only in carcinoma but in other types of intrathoracic disease. We believe that this procedure reduces the number of unnecessary exploratory thoracotomies. Carlens (1959) introduced diagnostic exploration sible. Biopsy in such cases can be obtained from tissues inside the thoracic inlet. in the of the superior mediastinum. The space explored just Bleeding, copyright. is part of the superior mediastinum which is presence of incipient or developed superior vena caval of the obstruction, or dense fibrosis of the pre-tracheal situated around tihe intrathoracic part fascia, can make the procedure difficult or impossible. -
Corrigendum for Open Surgical Instruments for the Department Of
Date: - 07th September, 2018 Corrigendum For Open Surgical Instruments for the Department of Surgical Oncology NIT Issue Date : 25th July, 2018 NIT No. : Admn/Tender/71/2018-AIIMS.JDH Pre-Bid Meeting : 06th August, 2018 at 04:00 PM Earlier Last Date of Submission : 04th September, 2018 at 03:00 PM Extended Last Date of Submission : 19th September, 2018 at 03:00 PM Bid opening : 20th September, 2018 at 03:15 P.M The following revised and additional specification will be added:- 1. Page No. 11 & 12 For S. No. Name of Surgical Instrument Quantity 1 SS TRAY LARGE 470X320X50MM 4 2 SS TRAY SMALL 350X240X40MM 8 3 KIDNEY DISH LARGE 250X140X40MM 8 4 KIDNEY DISH SMALL 170X100X35MM 10 5 SS BOWL 80X40MM 6 6 SS BOWL 166X50MM 6 7 SSBOWL 160X65MM 8 8 SS BOWL 147X65MM 8 9 SS DRUM LARGE 15X12 INCH 4 10 SS DRUM SMALL 11X9 INCH 4 11 BACKHAUS TOWEL CLAMP 13 CM 64 12 FORSTER SPONGE HOLDER 18 Cm 18 13 BP HANDLE NO. 3 8 14 BP HANDLE NO. 4 7 15 BP HANDLE NO. 7 9 16 SUCTION TIP 2MM 9 17 SUCTION TIP 5MM 8 18 YANKAUER SUCTION TIP 10 MM 4 19 SS SCALE 5 20 DEAVER RETRACTOR SMALL 18CM(TIP 19MM) 14 Corrigendum for Open Surgical Instruments at AIIMS Jodhpur Page 1 21 DEAVER RETRACTOR MEDIUM 30.5CM (TIP 25 MM) 10 22 DEAVER RETRACTOR LARGE 31.5CM (TIP 50MM) 10 23 DOYEN’S RETRACTOR 4 24 MORRIS RETRACTOR 25cm ( BLADE 7x4cm) 6 25 SKIN HOOK 32 26 LANGENBECK RETRACTOR SMALL 16cm (TIP 21x 8mm) 16 27 LANGENBECK RETRACTOR MEDIUM 22cm (TIP 50x11mm) 16 28 LANGENBECK RETRACTOR LARGE 22.5cm (TIP 85x15mm) 14 29 C ZERNY RETRACTOR 17.2 cm 14 30 VEIN RETRACTOR 18 31 BALFOUR ABDOMINAL RETRACTOR 20cm 3 32 MASTOID RETRACTOR 4 33 PERIOSTEUM ELEVATOR SHARP 4 34 PERIOSTEUM ELEVATOR BLUNT 4 35 DISSECTING TOOTH FORCEPS 15 CM 16 36 DISSECTING PLAIN FORCEPS 18 CM 16 37 ARTERY FORCEPS CVD 15 CM 36 38 ARTERY FORCEPS ST. -
Cervical Mediastinal L SUSAN ALEXANDER L for STAGING of LUNG CANCER
Cervical Mediastinal l SUSAN ALEXANDER l FOR STAGING OF LUNG CANCER ervical mediastinal exp- bronchogenic lung cancer by sam- loration (CME), or pling selected lymph nodes in and mediastinoscopy, is a around the trachea, its major surgical procedure to bifurcation and the great vessels. C explore and sample Lymph nodes are removed and lymph nodes in the space between sent to pathology for tissue diag- the lungs, (the mediastinum), nosis to determine the histology when diagnostic imaging studies of the tumor. CME is performed (X-ray, CT scan, etc) suggest a primarily to stage lung cancer growth in the lungs or mediasti- and determine the extent of the nal region. The most common pur- disease and establish treatment pose of the CME is to diagnose options. DECEMBER 2002 The Surgical Technologist 9 224 DECEMBER 2002 CATEGORY 1 If cancer exists in the lymph nodes, the cell type nodes that are not accessible through CME. In (histology) identifies the type of cancer and one series of 100 patients with tumors in this extent of the lymph nodes involved. If tumor area, 22 were found to be inoperable despite hav involvement in the mediastinal area is demon ing a negative mediastinoscopy.5 Left anterior strated in the pathology review of the speci- mediastinotomy through the second intercostal men(s) (lymph nodes), the patient may be space is the preferred method to assess the oper spared an unnecessary thoracotomy; however, ability of these patients, as suggested by Pearson this means that the tumor is inoperable.5 and coworkers.5 Less than 50% of patients undergoing cura History tive resection for bronchogenic carcinoma sur CME was originally described by Harken and vive five years. -
Experience with Video Mediastinoscopy at a Tertiary Cancer Center
Oncology and Radiotherapy © 1 (50) 2020: 001-005 • RESEARCH ARTICLE From radiological assumption to pathological conviction: experience with video mediastinoscopy at a tertiary cancer center Nizamudheen MP, Abhay K Kattepur, Satheesan B Department of Surgical Oncology, Malabar Cancer Centre, Thalassery, Kerala, India Purpose: To describe the role of mediastinoscopy in the setting of mediastinaladenopathy secondary to pulmonary and non-pulmonary cancers. INTRODUCTION Methods: Retrospective analysis of patients undergoing video mediastinoscopy SUMMARY from November 2016 to December 2018 at tertiary cancer center for Cervical mediastinoscopy is a time tested tool for the mediastinaladenopathy from lung cancer and non-pulmonary cancers with invasive staging of mediastinal nodes. Standard cervical mediastinal nodes. mediastinoscopy helpsin approaching lymph node stations viz. Results: Twelve patients were included out of which 11 patients underwent right upper paratracheal (station 2R), right lower paratracheal diagnostic mediastinoscopy. The median age was 58 years. Seven patients had lung cancer. The mean number of nodes sampled was 10.5 (range: (4R), left upper paratracheal (2L), right lower paratracheal 2-28 nodes). Five patients had mediastinaladenopathy from non-pulmonary (4L) and sub-carinal (7). Hilar nodes (station 10) can also cancer like endometrial, oropharyngeal and Hodgkin’s lymphoma. Recurrent laryngeal nerve palsy was noted in one patient. be accessed byexperienced surgeons, although it can be Conclusion: Mediastinoscopy serves as a valuable asset for staging of lung technically challenging. Overall, this procedure is accurate and cancer and in the assessment of suspicious nodes in the setting of non- carries minimal morbidity [1]. The role of mediastinoscopy pulmonary cancers. However, training and expertise is in the need of the hour to prevent redundancy of this valuable procedure.